Augmentin and Halcion drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Augmentin (amoxicillin; clavulanate potassium) and Halcion (triazolam). Common drug interactions include acute myocardial infarction among females and enthesopathy among males.

The phase IV clinical study analyzes what interactions people have when they take Augmentin and Halcion. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.

What is Augmentin?

Augmentin has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 42,620 Augmentin users. Check the latest studies of Augmentin.

What is Halcion?

Halcion has active ingredients of triazolam. It is often used in insomnia. eHealthMe is studying from 8,268 Halcion users. Check the latest studies of Halcion.



On Jul, 11, 2026

49 people who take Augmentin and Halcion together, and have interactions are studied.

Augmentin and Halcion drug interactions.

What are the common drug interactions of Augmentin and Halcion, by gender? *:

female:

  1. Acute myocardial infarction (acute heart attack)
  2. Alanine aminotransferase increased
  3. Anaemia (lack of blood)
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety
  6. Aspartate aminotransferase increased
  7. Atelectasis (partial or complete collapse of the lung)
  8. Back pain
  9. Bone disorder
  10. Bone pain

male:

  1. Enthesopathy (disorder of entheses (bone attachments))
  2. Myalgia (muscle pain)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Atelectasis (partial or complete collapse of the lung)
  6. Bone disorder
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Coagulopathy (blood's ability to clot is impaired)
  9. Deformity (disfigurement)
  10. Discomfort

What are the common drug interactions of Augmentin and Halcion, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)

10-19:

n/a

20-29:

  1. Completed suicide (act of taking one's own life)

30-39:

  1. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  2. Diabetic coma
  3. Diabetic ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies)
  4. Disturbance in attention
  5. Emotional distress
  6. Hyperglycaemia (high blood sugar)
  7. Hypertension (high blood pressure)
  8. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  9. Metabolic syndrome (a combination of the medical disorders that, when occurring together, increase the risk of developing cardiovascular disease)
  10. Obesity (having too much body fat)

40-49:

  1. Pneumonia
  2. Acute myocardial infarction (acute heart attack)
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Atelectasis (partial or complete collapse of the lung)
  6. Bone disorder
  7. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  8. Coagulopathy (blood's ability to clot is impaired)
  9. Deformity (disfigurement)
  10. Discomfort

50-59:

  1. Arthralgia (joint pain)
  2. Pain
  3. Serum sickness (hypersensitivity reaction that results from the injection of heterologous or foreign protein or serum)

60+:

  1. Febrile neutropenia (fever with reduced white blood cells)
  2. Blood sodium decreased
  3. Enthesopathy (disorder of entheses (bone attachments))
  4. Myalgia (muscle pain)
  5. Myopathy (a muscular disease in which the muscle fibres do not function)
  6. Tendon pain
  7. Adverse reaction
  8. Malignant neoplasm progression (cancer tumour came back)
  9. Carcinoid tumour (slow growing tumour)
  10. Haemodynamic instability (disturbances in the blood movement in our body)

What are the existing conditions these people have? *

  1. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 31 people, 63.27%
  2. Urethritis (inflammation of the urethra): 5 people, 10.20%
  3. Cerebral Infarction (less blood supply to brain resulting tissue damage): 5 people, 10.20%
  4. Pneumonia: 3 people, 6.12%
  5. Multiple Myeloma (cancer of the plasma cells): 3 people, 6.12%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin and Halcion?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Augmentin and Halcion:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Augmentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Halcion:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Augmentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Halcion and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on amoxicillin; clavulanate potassium and triazolam (the active ingredients of Augmentin and Halcion, respectively), and Augmentin and Halcion (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: